Dyne Therapeutics (DYN) stock gains premarket momentum as BMO Capital Markets issus a new Outperform rating on the company. Read more here.

BMO Capital analyst Kostas Biliouris initiated coverage of Dyne Therapeutics (DYN) with an Outperform rating and $50 price target The firm ...

BMO Capital analyst Keith Bachman initiated coverage of SailPoint (SAIL) with an Outperform rating and $26 price target The firm believes ...

Tariffs present an inflationary risk, but bank economists see mostly smooth sailing, with steady growth, modest unemployment ...

BMO Capital Markets’ price target would suggest a potential upside of 62.91% from the stock’s previous close. Several other equities analysts also recently issued reports on the stock.

Comical scenes at a tourist hotspot in Chongqing, China, as a woman was filmed 'eating' an entire train on 8. The viewing platform at Binjiang Park has become a thriving attraction for tourists and ...

BMO beat profit on capital markets, wealth management strength Alex Ovechkin is on track to break Wayne Gretzky's NHL career goals record ‘It’s not taxed at all’: Warren Buffett shares the ...

(Bloomberg) -- Bank of Montreal and Bank of Nova Scotia kicked off Canadian bank earnings season with strong results from their capital-markets divisions amid an increase in trading activity.

On Monday, BMO Capital Markets upgraded Century Aluminum (NASDAQ:CENX) shares from Market Perform to Outperform, setting a price target at $22.00. The upgrade comes as the analyst, Katja Jancic, sees ...

On Monday, BMO Capital Markets adjusted its stance on Block Inc. (NYSE: SQ), formerly known as Square, upgrading the company's stock rating from Market Perform to Outperform. The upgrade comes ...